A review of glycosylated carriers for drug delivery

Biomaterials

Volumn 33, Issue 16, 2012, Pages 4166-4186

  Jain, Keerti ^a   Kesharwani, Prashant ^a   Gupta, Umesh ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Carbohydrate; Glycosylated carriers; Lectin receptors; Ligand

Indexed keywords

BIOACTIVES; BUILDING BLOCKES; CELL SURFACES; DELIVERY SYSTEMS; DRUG CARRIER; DRUG DELIVERY VEHICLES; GLYCOSYLATED; IMMUNE RESPONSE; LECTIN RECEPTORS; LIVING CELL; LIVING SYSTEMS; NANOCARRIERS; NATURAL PRODUCTS; PHARMACOKINETIC PROFILES; RELEASE PROFILES; TARGETED DELIVERY; THERAPEUTIC AGENTS; THERAPEUTIC INDEX;

ANTIGENS; BIOLOGICAL SYSTEMS; CARBOHYDRATES; CELL MEMBRANES; LIGANDS;

DRUG DELIVERY;

ACICLOVIR; CARBOHYDRATE; CHITOSAN; CHLOROQUINE; DIAGNOSTIC AGENT; DOXORUBICIN; DRUG CARRIER; EFAVIRENZ; FUCOSE; GALACTOSE; GLYCOCONJUGATE; GLYCOSYLATED CARRIER; LAMIVUDINE; LECTIN RECEPTOR; LIPOSOME; MANNOSE; METHOTREXATE; PACLITAXEL; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RIFAMPICIN; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

BIOCOMPATIBILITY; BLOOD TOXICITY; CHEMICAL REACTION; CONJUGATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG TARGETING; ESTERIFICATION; GENE DELIVERY SYSTEM; GLYCOSYLATION; HUMAN; LIVER CELL; LUNG ALVEOLUS; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SUSTAINED DRUG RELEASE;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLYCOSYLATION; HUMANS; MICE; PHARMACOKINETICS; RECEPTORS, MITOGEN; TRANSFECTION; VACCINES;

EID: 84858798200     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.033     Document Type: Review

References (131)

1. Agrawal A., Saraf S., Asthana A., Gupta U., Gajbhiye V., Jain N.K. Ligand based dendritic systems for tumor targeting. Int J Pharm 2008, 350:3-13.
2. Monsigny M., Roche A.C., Midoux P., Mayer R. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv Drug Deliv Rev 1994, 14:1-24.
3. Wang Q., Zhang L., Hu W., Hu Z.H., Bei Y.Y., Xu J.Y., et al. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomed 2010, 6:371-381.
4. Jain K., Kesharwani P., Gupta U., Jain N.K. Dendrimer toxicity: Let's meet the challenge. Int J Pharm 2010, 394:122-142.
5. Nahar M., Dutta T., Murugesan S., Asthana A., Mishra D., Rajkumar V., et al. Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit Rev Ther Drug Carrier Syst 2006, 23:259-318.
6. Unverzagt C., Andre S., Seifert J., Kojima S., Fink C., Srikrishna G., et al. Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional α2,3/ α2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake. J Med Chem 2002, 45:478-491.
7. Budzynska R., Nevozhay D., Kanska U., Jagiello M., Opolski A., Wietrzyk J., et al. Antitumor activity of mannan-methotrexate conjugate in vitro and in vivo. Oncol Res 2007, 16:415-421.
8. Garg M., Dutta T., Jain N.K. Reduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomes. Eur J Pharm Biopharm 2007, 67:76-85.
9. Garg M., Jain N.K. Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes. J Drug Target 2006, 14:1-11.
10. Jain S., Singh P., Mishra V., Vyas S.P. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett 2005, 101:41-49.
11. Jain N.K., Jain S.K. Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin. AAPS Pharm Sci Tech 2010, 11:686-697.
12. Kawakami S., Sato A., Nishikawa M., Yamashita F., Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 2000, 7:292-299.
13. Kuramoto Y., Kawakami S., Zhou S., Fukuda K., Yamashita F., Hashida M. Use of mannosylated cationic liposomes/immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice. J Gene Med 2008, 10:392-399.
14. Kumar P.V., Asthana A., Dutta T., Jain N.K. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target 2006, 14:546-556.
15. Stewart A.J., Pichon C., Meunier L., Midoux P., Monsigny M., Roche A.C. Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine. Mol Pharmacol 1996, 50:1487-1494.
16. Bies C., Lehr C.M., Woodley J.F. Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev 2004, 56:425-435.
17. Wadhwa M.S., Rice K.G. Receptor mediated glycotargeting. J Drug Target 1995, 3:111-127.
18. Dutta T., Jain N.K. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim Biophys Acta 2007, 1770:681-686.
19. Wang J., Duan T., Sun L., Liu D., Wang Z. Functional gold nanoparticles for studying the interaction of lectin with glycosyl complex on living cellular surfaces. Anal Biochem 2009, 392:77-82.
20. Davis B.G., Robinson M.A. Drug delivery systems based on sugar macromolecule conjugates. Curr Opin Drug Discov Dev 2002, 5:279-288.
21. Kolomiets E., Swiderska M.A., Kadam R.U., Johansson E.M., Jaegerr K.E., Darbre T., et al. Glycopeptide dendrimers with high affinity for the fucose-binding lectin LecB from Pseudomonas aeruginosa. Chem Med Chem 2009, 4:562-569.
22. Darbre T., Reymond J.L. Glycopeptide dendrimers for biomedical applications. Curr Top Med Chem 2008, 8:1286-1293.
23. Kolomiets E., Johansson E.M., Renaudet O., Darbre T., Reymond J.L. Neoglycopeptide dendrimer libraries as a source of lectin binding ligands. Org Lett 2007, 9:1465-1468.
24. Lin A., Liu Y., Huang Y., Sun J., Wu Z., Zhang X., et al. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int J Pharm 2008, 359:247-253.
25. Magnusson S., Berg T. Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. Biochem J 1989, 257:651-656.
26. Nishikawa M., Yamauchi M., Morimoto K., Ishida E., Takakura Y., Hashida M., et al. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther 2000, 7:548-555.
27. Lin W.J., Chen M.H. Synthesis of multifunctional chitosan with galactose as a targeting ligand for glycoprotein receptor. Carbohydr Polym 2007, 67:474-480.
28. Sagara K., Kim S.W. A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J Control Rel 2002, 79:271-281.
29. Friedman B.A., Vaddi K., Preston C., Mahon E., Cataldo J.R., McPherson J.M. A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived β-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease. Blood 1999, 93:2807-2816.
30. Gordon S., Perry V.H., Rabinowitz S., Chung L.P., Rosen H. Plasma membrane receptors of the mononuclear phagocyte system. J Cell Sci Suppl 1988, 9:1-26.
31. Kelly C., Jefferies C., Cryan S.A. Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv 2010, 2011:1-11.
32. Regnier-Vigouroux A. The mannose receptor in the brain. Int Rev Cytol 2003, 226:321-342.
33. Takagi H., Numazaki M., Kajiwara T., Abe Y., Ishii M., Kato C., et al. Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages. Glycobiology 2009, 19:258-266.
34. Gazi U., Martinez P.L. Influence of the mannose receptor in host immune responses. Immunobiology 2009, 214:554-561.
35. Wileman T.E., Lennartz M.R., Stahl P.D. Identification of the macrophage mannose receptor as a 175-kDa membrane protein. Proc Natl Acad Sci 1986, 83:2501-2505.
36. Egan B.S., Abdolrasulnia R., Shepherd V.L. IL-4 modulates transcriptional control of the mannose receptor in mouse FSDC dendritic cells. Arch Biochem Biophys 2004, 428:119-130.
37. Irache J.M., Salman H.H., Gamazo C., Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 2008, 5:703-724.
38. McKenzie E.J., Taylor P.R., Stillion R.J., Lucas A.D., Harris J., Gordon S., et al. Mannose receptor expression and function define a new population of murine dendritic cells. J Immunol 2007, 178:4975-4983.
39. Tang C.K., Lodding J., Minigo G., Pouniotis D.S., Plebanski M., Scholzen A., et al. Mannan-mediated gene delivery for cancer immunotherapy. Immunol 2007, 120:325-335.
40. Diebold S.S., Kursa M., Wagner E., Cotton M., Zenke M. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 1999, 274:19087-19094.
41. Zhou X., Liu B., Yu X., Zha X., Zhang X., Chen Y., et al. Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine. J Control Rel 2007, 121:200-207.
42. Fiete D., Srivastava V., Hindsgaul O., Baenziger J.U. A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4Glc NAc beta 1,2Man alpha that mediates rapid clearance of lutropin. Cell 1991, 67:1103-1110.
43. Kempka G., Roos P.H., Kolb-Bachofen V. A membrane-associated form of C-reactive protein is the galactose-specific particle receptor on rat liver macrophages. J Immunol 1990, 144:1004-1009.
44. Opanasopit P., Shirashi K., Nishikawa M., Yamashita F., Takakura Y., Hashida M. In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein. Am J Physiol Gastrointest Liver Physiol 2001, 280:G879-G889.
45. Shepherd V.L., Lee Y.C., Schlesinger P.H., Stahl P.D. L-fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages. Proc Natl Acad Sci USA 1981, 78:1019-1022.
46. Vodovozova E.L., Moiseeva E.V., Grechko G.K., Gayenko G.P., Nifant'ev N.E., Bovin N.V., et al. Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model. Eur J Cancer 2000, 36:942-949.
47. Nantwi P.K., Cook D.J., Rogers D.J., Smart J.D. Lectins for drug delivery within the oral cavity-investigation of lectin binding to oral mucosa. J Drug Target 1997, 5:45-55.
48. Nicholls T.J., Green K.L., Rogers D.J., Cook J.D., Wolowacz S., Smart J.D. Lectins in ocular drug delivery: an investigation of lectin binding sites on the corneal and conjunctival surfaces. Int J Pharm 1996, 138:175-183.
49. Dutta T., Agashe H.B., Garg M., Balasubramanium P., Kabra M., Jain N.K. Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. J Drug Target 2007, 15:89-98.
50. Agashe H.B., Dutta T.D., Garg M., Jain N.K. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. J Pharm Pharmacol 2006, 58:1491-1498.
51. Espuelas S., Haller P., Schuber F., Frisch B. Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers. Bioorg Med Chem Lett 2003, 13:2557-2560.
52. Agrawal A., Gupta U., Asthana A., Jain N.K. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 2009, 30:3588-3596.
53. Agrawal P., Gupta U., Jain N.K. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 2007, 28:3349-3359.
54. Bhadra D., Yadav A.K., Bhadra S., Jain N.K. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm 2005, 295:221-233.
55. Mitchell J.P., Roberts K.D., Langley J., Koentegen F., Lambert J.N. A direct method for the formation of peptide and carbohydrate dendrimers. Biol Med Chem Lett 1999, 9:2785-2788.
56. Frisch B., Hassane F.S., Schuber F. Conjugation of ligands to the surface of preformed liposomes by click chemistry. Methods Mol Biol 2010, 605:267-277.
57. Maruyama A., Ishihara T., Adachi N., Akaike T. Preparation of nanoparticles bearing high density carbohydrate chains using carbohydrate-carrying polymers as emulsifier. Biomaterials 1994, 15:1035-1042.
58. Macmillan D., Daines A.M. Recent developments in the synthesis and discovery of oligosaccharides and glycoconjugates for the treatment of disease. Curr Med Chem 2003, 10:2733-2773.
59. Okada M. Molecular design and syntheses of glycopolymers. Prog Polym Sci 2001, 26:67-104.
60. Schlick K.H., Cloninger M.J. Inhibition binding studies of glycodendrimer/ lectin interactions using surface Plasmon resonance. Tetrahedron 2010, 66:5305-5310.
61. Mazzaglia A., Valerio A., Villari V., Rencurosi A., Lay L., Spadaro S., et al. Probing specific protein recognition by size-controlled glycosylated cyclodextrin nanoassemblies. New J Chem 2006, 30:1662-1668.
62. Sett R., Sarkar H.S., Das P.K. Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin. J Antimicrob Chemother 1993, 31:151-159.
63. Suriano F., Pratt R., Tan J.P., Wiradharma N., Nelson A., Yang Y.Y., et al. Synthesis of a family of amphiphilic glycopolymers via controlled ring-opening polymerization of functionalized cyclic carbonates and their application in drug delivery. Biomaterials 2010, 31:2637-2645.
64. Oda Y., Yanagisawa H., Maruyama M., Hattori K., Yamanoi T. Design, synthesis and evaluation of D-galactose-beta-cyclodextrin conjugates as drug-carrying molecules. Bioorg Med Chem 2008, 16:8830-8840.
65. Malingre M.M., Beijnen J.H., Schellens J.H.M. Oral delivery of taxanes. Invest New Drugs 2001, 19:155-162.
66. Ponchel G., Irache J.M. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Del Rev 1998, 191-219.
67. Gabor F., Bogner E., Weissenboeck A., Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliv Rev 2004, 56:459-480.
68. Pukanud P., Peungvicha P., Sarisuta N. Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer's patches. Drug Deliv 2009, 16:289-294.
69. Salman H.H., Gamazo C., Campanero M.A., Irache J.M. Bioadhesive mannosylated nanoparticles for oral drug delivery. J Nanosci Nanotechnol 2006, 6:3203-3209.
70. Fievez V., Plapied L., Rieux A., Pourcelle V., Freichels H., Wascotte V., et al. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur J Pharm Biopharm 2009, 73:16-24.
71. Salman H.H., Irache J.M., Gamazo C. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccine 2009, 27:4784-4790.
72. Jain A., Agrawal A., Majumder S., Lariya N., Kharya A., Agrawal H., et al. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Rel 2010, 148:359-367.
73. Kim I.S., Kim S.H. Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety. Int J Pharm 2003, 257:195-203.
74. Dennis J.W., Granovsky M., Warren C.E. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999, 1473:21-34.
75. Kesharwani P., Tekade R.K., Gajbhiye V., Jain K., Jain N.K. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine 2011, 7:295-304.
76. Liang H.F., Chen C.T., Chen S.C., Kulkarni A.R., Chiu Y.L., Chen M.C., et al. Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials 2006, 27:2051-2059.
77. Matsui M., Shimizu Y., Kodera Y., Kondo E., Ikehara Y., Nakanishi H. Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. Cancer Sci 2010, 101:1670-1677.
78. Peng J., Wang K., Tan W., He X., He C., Wu P., et al. Identification of live liver cancer cells in a mixed cell system using galactose-conjugated fluorescent nanoparticles. Talanta 2007, 71:833-840.
79. Hashida M., Nishikawa M., Yamashita F., Takakura Y. Cell-specific delivery of genes with glycosylated carriers. Adv Drug Deliv Rev 2001, 52:187-196.
80. Kawakami S. Development and application of glycosylated particulate carriers for delivery of nucleic acid medicine. J Pharma Soc Jpn 2008, 128:1743-1749.
81. Park I.Y., Kim I.Y., Yoo M.K., Choi Y.J., Cho M.H., Cho C.S. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Int J Pharm 2008, 359:280-287.
82. Jiang H.L., Kang M.L., Quan J.S., Kang S.G., Akaike T., Yoo H.S., et al. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials 2008, 29:1931-1939.
83. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Development of an ultrasound-responsive and mannose modified gene carrier for DNA vaccine therapy. Biomaterials 2010, 31:7813-7826.
84. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum Gene Ther 2010, 21:65-74.
85. Katnik-Prastowska I., Orczyk-Pawliowicz M. Expression and potential biological role of α(1,2)fucosylated glycotopes on amniotic and seminal fibronectins. Biochem Soc Trans 2011, 39:355-359.
86. Orczyk-Pawilowicz M., Katnik-Prastowska I. Terminal monosaccharide expression on amniotic glycoproteins as biomarkers of fetus maturity. Biochem Soc Trans 2011, 39:344-348.
87. Kikkeri R., Lepenies B., Adibekian A., Laurino P., Seeberger P.H. In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots. J Am Chem Soc 2009, 131:2110-2112.
88. Benito J.M., Gomez-Garcia M., Ortiz Mellet C., Baussanne I., Defaye J., Garcia Fernandez J.M. J Am Chem Soc 2004, 126:10355-10363.
89. Wu D.Q., Li Z.Y., Li C., Fan J.J., Lu B., Chang C., et al. Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy. Pharm Res 2010, 27:187-199.
90. Lherm C., Muller R.H., Puisieux F., Couvreur P. Alkylcyanoacrylate drug carriers: cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm 1992, 84:13-22.
91. Nahar M., Mishra D., Dubey V., Jain N.K. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine 2008, 4:252-261.
92. Stahl P.D., Rodman J.S., Miller M.J., Schlesinger P.H. Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages. Proc Natl Acad Sci USA 1978, 75:1399-1403.
93. Chono S., Tanino T., Seki T., Morimoto K. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J Control Rel 2008, 127:50-58.
94. Verma R.K., Kaur J., Kumar K., Yadav A.B., Misra A. Intracellular time course, pharmacokinetics, and biodistribution isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice. Antimicrob Agents Chemother 2008, 52:3195-3201.
95. Chono S., Kaneko K., Yamamoto E., Togami K., Morimoto K. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages. Drug Dev Ind Pharm 2009, 36:102-107.
96. Wijagkanalan W., Kawakami S., Takenaga M., Igarashi R., Yamashita F., Hashida M. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Rel 2008, 125:121-130.
97. Opanasopit P., Nishikawa M., Yamashita F., Takakura Y., Hashida M. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells. J Drug Target 2001, 9:341-351.
98. Akamatsu K., Imai M., Yamasaki Y., Nishikawa M., Takakura Y., Hashida M. Disposition characteristics of glycosylated poly (amino acids) as liver cell-specific drug carrier. J Drug Target 1998, 6:229-239.
99. Yeeprae W., Kawakami S., Higuchi Y., Yamashita F., Hashida M. Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice. J Drug Target 2005, 13:479-487.
100. Yeeprae W., Kawakami S., Yamashita F., Hashida M. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Rel 2006, 114:193-201.
101. Kawakami S., Wong J., Sato A., Hattori Y., Yamashita F., Hashida M. Biodistribution characteristics of mannosylated, fucosylated and galactosylated liposomes in mice. Biochim Biophys Acta 2000, 1524:258-265.
102. Nag A., Ghosh P.C. Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver. J Drug Target 1999, 6:427-438.
103. Fiume L., Busi C., Di Stefano G., Mattioli A. Targeting of antiviral drugs to the liver using glycoprotein carriers. Adv Drug Del Rev 1994, 14:51-65.
104. Frese J., Wu C.H., Wu G.Y. Targeting of genes to the liver with glycoprotein carriers. Adv Drug Del Rev 1994, 14:137-152.
105. Julyan P.J., Seymour L.W., Ferry D.R., Daryani S., Boivin C.M., Doran J., et al. Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine. J Control Rel 1999, 57:281-290.
106. Cho C.S., Cho K.Y., Park I.K., Kim S.H., Sasagawa T., Uchiyama M., et al. Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene. J Control Rel 2001, 77:7-15.
107. Seo S.J., Moon H.S., Guo D.D., Kim S.H., Akaike T., Cho C.S. Receptor mediated delivery of all-trans-retinoic acid (ATRA) to hepatocytes from ATRA-loaded poly(N-p-vinylbenzyl-4-o-β-d-galactopyranosyl-d-gluconamide) nanoparticles. Mater Sci Eng C 2006, 26:136-141.
108. Xu Z., Chen L., Gu W., Gao Y., Lin L., Zhang Z., et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009, 30:226-232.
109. Higuchi Y., Kawakami S., Yamashita F., Hashida M. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease. Biomaterials 2007, 28:532-539.
110. Auger M.J., Ross J.A. The biology of the macrophage. The natural immune system: the macrophage 1992, Oxford University Press, New York. 1st ed. C.E. Lewis, J.O.D. Mcgee (Eds.).
111. Ravichandran K.S., Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007, 7:964-974.
112. Owais M., Gupta C.M. Targeted drug delivery to macrophages in parasitic infections. Curr Drug Del 2005, 2:311-318.
113. McGreal E.P., Martinez-Pomares L., Gordon S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004, 41:1109-1121.
114. Kole L., Das L., Das P.K. Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis. J Infect Dis 1999, 180:811-820.
115. Engel A., Chatterjee S.K., Al-arifi A., Riemann D., Langner J., Nuhn P. Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells. Pharm Res 2003, 20:51-57.
116. Nakamura K., Kuramoto Y., Mukai H., Kawakami S., Higuchi Y., Hashida M. Enhanced gene transfection in macrophages by histidine-conjugated mannosylated cationic liposomes. Biol Pharm Bull 2009, 32:1628-1631.
117. Garg M., Garg B.R., Jain S., Mishra P., Sharma R.K., Mishra A.K., et al. Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99m Tc labeled galactosylated liposomes. Eur J Pharm Sci 2008, 33:271-281.
118. Jain S.K., Gupta Y., Jain A., Saxena A.R., Khare P., Jain A. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine 2008, 4:41-48.
119. Kaur C.D., Nahar M., Jain N.K. Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target 2008, 16:798-805.
120. Johansson E.M., Crusz S.A., Kolomiets E., Buts L., Kadam R.U., Cacciarini M., et al. Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptides dendrimers targeting the fucose-specific lectin LecB. Chem Biol 2008, 15:1249-1257.
121. Shepherd V.L., Konish M.G., Stahl P. Dexamethasone increases expression of mannose receptors and decreases extracellular lysosomal enzyme accumulation in macrophages. J Biol Chem 1985, 260:160-164.
122. Cowan H.B., Vick S., Conary J.T., Shepherd V.L. Dexamethasone up-regulates mannose receptor activity by increasing mRNA levels. Arc Biochem Biophys 1992, 296:314-320.
123. Zhu Y., Xuemei L., Schuchman E.H., Desnick R.J., Cheng S.H. Dexamethasone-mediated up-regulation of the mannose receptor improves the delivery of recombinant glucocerebrosidase to gaucher macrophages. J Pharmacol Exp Ther 2004, 308:705-711.
124. Beharka A.A., Gaynor C.D., Kang B.K., Voelker D.R., McCormack F.X., Schlesinger L.S. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002, 169:3563-3573.
125. Fiume L., Di Stefano G. Lactosaminated human albumin, a hepatotropic carrier of drugs. Eur J Pharm Sci 2010, 40:253-262.
126. Gou M.L., Dai M., Li X.Y., Yang L., Huang M.J., Wang Y.S., et al. Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity. Colloids Surf B Biointerfaces 2008, 64:135-139.
127. Jeong Y.-I.I., Seo S.J., Park I.K., Lee H.C., Kang I.C., Akaike T., et al. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl 1-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 2005, 296:151-161.
128. Huang G., Diakur J., Xu Z., Wiebe L.I. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Int J Pharm 2008, 360:197-203.
129. Zhang F., Wu Q., Chen Z.C., Zhang M., Lin X.F. Hepatic-targeting microcapsules construction by self-assembly of bioactive galactose-branched polyelectrolyte for controlled drug release system. J Colloid Interface Sci 2008, 317:477-484.
130. Wang S., Xu H., Xu J., Zhang Y., Liu Y., Deng Y.H., et al. Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid. AAPS Pharm Sci Tech 2010, 11:870-877.
131. Zhang X.Q., Wang X.L., Zhang P.C., Liu Z.L., Zhuo R.X., Mao H.Q., et al. J Control Rel 2005, 102:749-763.